DocuSign, Inc. (DOCU) stock
DOCUNasdaqServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 12/3028% above fair value
$80.15+0.00 (0.00%)
Close on Nov 12, 2026Market cap $14.98BP/E 48.9Yield –
DocuSign EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
DocuSign's EPS for the twelve months ending Jul 31, 2026 was $1.64, up 23.3% year over year. For fiscal 2026 it was $1.48, down 70.9% from the year before. The highest annual figure on record is $5.08 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.48 | -70.9% |
| FY2025 | Jan 31, 2025 | $5.08 | +1311.1% |
| FY2024 | Jan 31, 2024 | $0.36 | – |
| FY2023 | Jan 31, 2023 | -$0.49 | – |
| FY2022 | Jan 31, 2022 | -$0.36 | – |
| FY2021 | Jan 31, 2021 | -$1.31 | – |
| FY2020 | Jan 31, 2020 | -$1.18 | – |
| FY2019 | Jan 31, 2019 | -$3.16 | – |
| FY2018 | Jan 31, 2018 | -$1.66 | – |
| FY2017 | Jan 31, 2017 | -$4.17 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $0.40 | +33.3% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $0.40 | +17.6% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $0.44 | +12.8% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $0.40 | +33.3% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $0.30 | -93.0% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $0.34 | +112.5% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $0.39 | +200.0% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $0.30 | +57.9% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $4.26 | +10550.0% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $0.16 | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $0.13 | +550.0% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $0.19 | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $0.04 | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $0.00 | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $0.02 | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$0.15 | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$0.22 | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$0.14 | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$0.15 | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$0.03 | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$0.13 | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$0.04 | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$0.38 | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$0.31 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$0.35 | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$0.26 | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$0.26 | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$0.26 | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$0.39 | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$0.27 | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$0.31 | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$0.22 | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$7.46 | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$0.20 | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$0.45 | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$0.39 | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$0.66 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?